Ipilimumab and Nivolumab in Leptomeningeal Metastases
Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This research study is studying a combination of two drugs as a possible treatment for
Leptomeningeal Metastases.
The names of the study interventions involved in this study are:
- Ipilimumab
- Nivolumab